CClinicalTrials.gg
CompletedNCT03448913BREASTUpdated Mar 12, 2019

Block REducing Pain After Surgery Trial

An observational study in Chronic Pain Post-Procedural, sponsored by University of Padova. Completed at 1 site in Italy. Open to participants aged 18 Years to 86 Years. Per ClinicalTrials.gov, last updated 2019-03-12.

Sponsored by University of Padova · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
140
Ages
18 Years to 86 Years
Sex
All
01

Study summary

This observational study evaluates difference in chronic pain after six months from surgery between patients who received PECS block and general anesthesia versus general anesthesia alone.

Read the detailed description

PECS block is used as a pain relief technique during breast surgery. However at the actual state of knowledge there is no strong evidence that its use could lower incidence of chronic pain compared to general anesthesia alone.

Moreover for its use an adequate skill with ultrasound machine is required. For this reason only some anesthesiologists in our reality use this technique it in clinical practice.

02

Conditions studied

  • Chronic Pain Post-Procedural

Browse trials for

Keywords

  • Anesthesia, Regional ;PECS block
03

Who can participate

Ages eligible
18 Years to 86 Years
Sexes eligible
All
Sampling method
Probability sample

Study population

Patients needing breast surgery (mastectomy, partial mastectomy and/or axillary clearence)

Inclusion criteria

  • programmed breast surgery
  • informed consent

Exclusion criteria

Exclusion Criteria:

  • bilateral breast surgery
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
140 participants (actual)
Patient registry
No

Groups and cohorts

  • PECS block+ General anesthesia

    Patients undergoing mastectomy, partial mastectomy and/or axillary clearance who received PECS block AND general anesthesia for the surgery.

    Procedure: PECS block

  • General anesthesia

    Patients undergoing mastectomy, partial mastectomy and/or axillary clearance who received general anesthesia only for the surgery.

Interventions

  • ProcedurePECS block

    It consists in injection of 20-30 ml of local anesthetic between pectoral minor, pectoral major, and serratus muscles.

05

What researchers measure

Primary outcomes

  1. Chronic pain at six months

    Presence of chronic pain at six months after surgery. For this purpose patient will be asked to report presence of pain on breast, neck, axilla or arm. If patient will report pain a further question about intensity (NRS) and quality (we will ask to patient to describe with words from one to three the pain). Furthermore we will ask to patient if he had take any action (eg drugs) to treat pain

    Time frame: six months

Secondary outcomes

  1. Chronic pain at three months

    Presence of chronic pain at three months after surgery. For this purpose patient will be asked to report presence of pain on breast, neck, axilla or arm. If patient will report pain a further question about intensity (NRS) and quality (we will ask to patient to describe with words from one to three the pain). Furthermore we will ask to patient if he had take any action (eg drugs) to treat pain

    Time frame: three months

  2. Chronic pain at nine months

    Presence of chronic pain at nine months after surgery. For this purpose patient will be asked to report presence of pain on breast, neck, axilla or arm. If patient will report pain a further question about intensity (NRS) and quality (we will ask to patient to describe with words from one to three the pain). Furthermore we will ask to patient if he had take any action (eg drugs) to treat pain

    Time frame: nine months

  3. Chronic pain at twelve months

    Presence of chronic pain at twelve months after surgery. For this purpose patient will be asked to report presence of pain on breast, neck, axilla or arm. If patient will report pain a further question about intensity (NRS) and quality (we will ask to patient to describe with words from one to three the pain). Furthermore we will ask to patient if he had take any action (eg drugs) to treat pain

    Time frame: twelve months

  4. Difference in opioid consumption during surgery

    Difference in opioid consumption during surgery (Fentanyl as mcg/kg/h; Remifentanil as mcg/kg/min)

    Time frame: day of surgery

  5. Difference in pain in the first 24 hours after surgery

    maximum and mean NRS score in the first 24 hours after surgery

    Time frame: first 24 hours after surgery

06

Study locations

1 site
  • University of Padova
    Padova, 35127, Italy
07

References and documents

Publications

  • Cronin-Fenton DP, Norgaard M, Jacobsen J, Garne JP, Ewertz M, Lash TL, Sorensen HT. Comorbidity and survival of Danish breast cancer patients from 1995 to 2005. Br J Cancer. 2007 May 7;96(9):1462-8. doi: 10.1038/sj.bjc.6603717. Epub 2007 Apr 3. PubMed 17406360 ↗
  • Andersen KG, Kehlet H. Persistent pain after breast cancer treatment: a critical review of risk factors and strategies for prevention. J Pain. 2011 Jul;12(7):725-46. doi: 10.1016/j.jpain.2010.12.005. Epub 2011 Mar 24. PubMed 21435953 ↗
  • Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA. Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer. 2005 Jan 31;92(2):225-30. doi: 10.1038/sj.bjc.6602304. PubMed 15655557 ↗
  • Blanco R. The 'pecs block': a novel technique for providing analgesia after breast surgery. Anaesthesia. 2011 Sep;66(9):847-8. doi: 10.1111/j.1365-2044.2011.06838.x. No abstract available. PubMed 21831090 ↗
  • Wijayasinghe N, Andersen KG, Kehlet H. Analgesic and Sensory Effects of the Pecs Local Anesthetic Block in Patients with Persistent Pain after Breast Cancer Surgery: A Pilot Study. Pain Pract. 2017 Feb;17(2):185-191. doi: 10.1111/papr.12423. Epub 2016 Feb 9. PubMed 26857336 ↗

Individual participant data

Plan to share: Undecided — De.identified individual participant data for all primary and secondary measures will be probably be made available

08

Registry details

Key details

Study ID
NCT03448913
Lead sponsor
University of Padova
Responsible party
Alessandro De Cassai (Medical Doctor, University of Padova) — Principal investigator
First posted
Feb 28, 2018
Start date
Feb 1, 2018
Primary completion
Mar 1, 2019
Completion
Mar 1, 2019
Last update
Mar 12, 2019

Study contacts

Alessandro De Cassai, MD
principal investigator · University of Padova

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2019. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion